Physician profile
Alejandra J Rivera
NPI 1831738491
$1,522.36
in general payments reported to CMS, 2019-2025
18 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $96.84 · 2022: $191 · 2023: $532 · 2024: $550 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,234.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $433.28 | 2021-2025 | Lifevest |
| Pfizer INC. | $198.25 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $136.88 | 2023-2024 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $104.39 | 2024 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $83.98 | 2023-2024 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $80.34 | 2023-2025 | Farxiga |
| Novartis Pharmaceuticals Corporation | $76.63 | 2021-2025 | |
| Alnylam Pharmaceuticals INC. | $66.44 | 2022-2024 | Onpattro, Amvuttra |
| Kestra Medical Technology Services, INC. | $65.67 | 2025 | Assure Wcd |
| Daiichi Sankyo INC. | $58.44 | 2023 | Injectafer |
| Zoll Circulation INC | $35.32 | 2021 | |
| Merck Sharp & Dohme LLC | $33.44 | 2023 | Verquvo |
| Cvrx, INC. | $32.35 | 2021-2024 | Barostim Neo System |
| Genentech USA, INC. | $28.55 | 2024 | Phesgo, Kadcyla, Perjeta |
| Medtronic, INC. | $27.63 | 2024 | Cobalt Dr Mri Surescan |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $25.41 | 2024 | |
| Scpharmaceuticals INC. | $18.52 | 2023 | |
| Chiesi USA, INC. | $16.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandra Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.